Herb Profile

Valeriana Officinalis

Valeriana officinalis

Valerian may support sleep onset and nighttime relaxation, with results varying by root preparation.

Last reviewed: 5 sources citedReport a correctionProfile-wide ·B Moderate

Use extra caution Drowsiness; dizziness; rare withdrawal like symptoms Details

Evidence
Moderate Evidence
Typical onset
Varies by prep
Safety rating
Moderate caution
Best for
Sleep, Stress, Cognitive function
Avoid / review if
Pregnancy, Caution With Alcohol, CNS Depressants
Valeriana Officinalis monograph visual
The Hippie Scientist
Verdict: Valeriana OfficinalisMaybe

Best for

  • Trouble falling asleep
  • People wanting a traditional herbal sedative
  • Occasional use

Not ideal for

  • Reliable, predictable results
  • Fast onset the very first night
  • Use with sedatives or alcohol
Evidence confidence
Mixed — some positive trials, inconsistent overall
Expected onset
Often builds over several days to 2 weeks
Give it
2–4 weeks
Bottom line: The classic sleep herb, but the evidence is genuinely mixed and effects vary between people and products. Worth a fair trial; do not expect consistency.

Safety: Avoid combining with alcohol or other sedatives; some report grogginess.

On the evidence: Trials conflict, partly due to variable extract quality.

Permanent link to this scientific verdict
How strong is the evidence?Limited — mixed

Why not higher

  • Trials genuinely conflict
  • Extract quality and dose vary widely between products
  • Effects are inconsistent between people

Why not lower

  • Some randomized trials do show a sleep-onset benefit
  • Long traditional use with an acceptable short-term safety profile

Practical takeaway: Worth a fair trial for trouble falling asleep, but manage expectations — results vary. Avoid combining with alcohol or other sedatives.

Next steps

Start here

New to this? Begin with Best herbs for sleep.

Compare first

Continue reading

Safety

Safety & Cautions

Drowsiness; dizziness; rare withdrawal like symptoms

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy
  • Caution With Alcohol
  • CNS Depressants
  • Benzodiazepines

Full safety note

  • Drowsiness; dizziness; rare withdrawal like symptoms

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedNeurotransmitter Modulation · Stress Response Modulation

Research maturity: Established researchLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableDrowsiness; dizziness; rare withdrawal like symptoms

This profile cites 5 human studies.

Study design details
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta-analysis
Risk of Bias
Low
Consistency
Consistent
Strongest recorded design is a meta-analysis, drawn from 8 recorded studies, 6 in people. No disagreement is recorded across them.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (7)4 human evidence sources · 1 human trial · ~1,093 participants across 1 human evidence source with reported N · Consistency not yet classifiable

Filter by study class

Showing 7 of 7 studies.

What the evidence actually shows

This table contains 7 structured sources, including 4 human evidence sources; 1 is a human trial. Across 1 human evidence source with a reported sample size, the approximate participant total is 1,093; overlapping publications may include some of the same people. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and Meta-Analysis

Shinjyo N et al. · J Evid Based Integr Med · 2020

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

PubMed

Valerian for sleep: a systematic review and meta-analysis

PubMed · Am J Med · 2006

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

n=1093PubMed

Background
Systematic review

Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.

Source

Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

Valerian-hops increased mean sleep duration by 21.7 minutes/day versus placebo (p=0.019) and increased the shortest-night sleep duration by 48.7 minutes.PubMed

Herbal Products Used in Menopause and for Gynecological Disorders

Kenda M et al. · Molecules · 2021

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Anti-anxiety Properties of Selected Medicinal Plants

Khan A et al. · Curr Pharm Biotechnol · 2022

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed
Show 1 more study

Does valerian work for insomnia? An umbrella review of the evidence

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

The review concluded that valerian does not have robust empirical support for insomnia.PubMed

Dosing & Timing

Dose guidance
Standardized extract (0.3 0.8% valerenic acids): 400 600 mg taken 30 60 min before sleep; tea preparations less standardized
How Valeriana Officinalis works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Valeriana Officinalis Works

How Valeriana Officinalis WorksValeriana Officinalis acts on biological target pathways via neurotransmitter (modulation), leading to sleep quality.Valeriana OfficinalisBiological TargetBiological pathwayNeurotransmitterModulationSleep Quality ↑Onset + depthHPA AxisModulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

  • Neurotransmitter Modulation
  • Stress Response Modulation

Active Compounds

Key constituents studied in Valeriana Officinalis, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Valeriana Officinalis

Goal guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Valerian product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Valeriana Officinalis, verify the label for:

  • Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Valeriana Officinalis research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Botanical profile context

How to interpret Valeriana Officinalis

Valeriana Officinalis herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Valeriana Officinalis, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.